5,7-dihydroxytryptamine has been researched along with Adjuvant Arthritis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Foletto, V; Lucena, F; Mascarin, LZ; Tonussi, CR | 1 |
Harbuz, MS; Jessop, DS; Lightman, SL; Marti, O | 1 |
2 other study(ies) available for 5,7-dihydroxytryptamine and Adjuvant Arthritis
Article | Year |
---|---|
Analgesic and anti-edematogenic effects of oral trypsin were abolished after subdiaphragmatic vagotomy and spinal monoaminergic inhibition in rats.
Topics: 5,7-Dihydroxytryptamine; Administration, Oral; Adrenergic Agents; Analgesics; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Edema; Female; Injections, Spinal; Nociception; Oxidopamine; Rats, Wistar; Serotonin Agents; Trypsin; Vagotomy | 2016 |
Alteration of central serotonin modifies onset and severity of adjuvant-induced arthritis in the rat.
Topics: 5,7-Dihydroxytryptamine; Animals; Arthritis, Experimental; Brain; Corticosterone; Corticotropin-Releasing Hormone; Edema; Hindlimb; Hydroxyindoleacetic Acid; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Pro-Opiomelanocortin; Rats; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 1998 |